Contact
CURING THE INCURABLE
Close
Neurodon is a development-stage pharmaceutical company that is developing disease-modifying molecules targeting neurodegeneration, diabetes, and other life-threatening conditions by deploying a proprietary ER stress-based technology platform — halting diseases and improving lives with innovative small molecule therapies.
Neurodon is a development-stage pharmaceutical company that is developing disease-modifying molecules targeting neurodegeneration, diabetes, and other life-threatening conditions by deploying a proprietary ER stress-based technology platform — halting diseases and improving lives with innovative small molecule therapies.
© Copyright | Neurodon | All Rights Reserved | Designed by Kucsera Design